Grimes & Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.4M | Buy |
805,088
+9,806
| +1% | +$257K | 0.42% | 50 |
|
|
2026
Q1 | $22.3M | Buy |
795,282
+5,332
| +0.7% | +$142K | 0.62% | 32 |
|
|
2025
Q4 | $19.7M | Buy |
789,950
+684,303
| +648% | +$17.3M | 0.47% | 39 |
|
|
2025
Q3 | $2.69M | Buy |
105,647
+7,875
| +8% | +$194K | 0.07% | 159 |
|
|
2025
Q2 | $2.37M | Buy |
97,772
+2,089
| +2% | +$48.7K | 0.06% | 154 |
|
|
2025
Q1 | $2.42M | Buy |
95,683
+1,854
| +2% | +$48.5K | 0.08% | 134 |
|
|
2024
Q4 | $2.49M | Sell |
93,829
-4,097
| -4% | -$111K | 0.07% | 137 |
|
|
2024
Q3 | $2.83M | Buy |
97,926
+4,969
| +5% | +$145K | 0.08% | 122 |
|
|
2024
Q2 | $2.6M | Buy |
92,957
+4,915
| +6% | +$135K | 0.08% | 123 |
|
|
2024
Q1 | $2.44M | Sell |
88,042
-12,029
| -12% | -$334K | 0.08% | 126 |
|
|
2023
Q4 | $2.88M | Buy |
100,071
+14,488
| +17% | +$438K | 0.1% | 112 |
|
|
2023
Q3 | $2.84M | Sell |
85,583
-456
| -0.5% | -$16.1K | 0.11% | 105 |
|
|
2023
Q2 | $3.16M | Sell |
86,039
-3,640
| -4% | -$142K | 0.11% | 101 |
|
|
2023
Q1 | $3.66M | Buy |
89,679
+8,113
| +10% | +$350K | 0.15% | 94 |
|
|
2022
Q4 | $4.18M | Buy |
81,566
+824
| +1% | +$39.5K | 0.18% | 96 |
|
|
2022
Q3 | $3.53M | Buy |
80,742
+95
| +0.1% | +$4.62K | 0.18% | 90 |
|
|
2022
Q2 | $4.23M | Buy |
80,647
+141
| +0.2% | +$7.18K | 0.21% | 90 |
|
|
2022
Q1 | $4.17M | Sell |
80,506
-55
| -0.1% | -$2.85K | 0.22% | 95 |
|
|
2021
Q4 | $4.76M | Sell |
80,561
-418
| -0.5% | -$20.7K | 0.22% | 87 |
|
|
2021
Q3 | $3.48M | Sell |
80,979
-1,097
| -1% | -$48.6K | 0.15% | 99 |
|
|
2021
Q2 | $3.21M | Sell |
82,076
-3,725
| -4% | -$145K | 0.14% | 100 |
|
|
2021
Q1 | $3.11M | Buy |
85,801
+9,691
| +13% | +$344K | 0.15% | 99 |
|
|
2020
Q4 | $2.8M | Sell |
76,110
-3,064
| -4% | -$112K | 0.15% | 100 |
|
|
2020
Q3 | $2.76M | Buy |
79,174
+413
| +0.5% | +$14.5K | 0.18% | 96 |
|
|
2020
Q2 | $2.44M | Buy |
78,761
+98
| +0.1% | +$3.33K | 0.17% | 95 |
|
|
2020
Q1 | $2.44M | Buy |
78,663
+5,195
| +7% | +$177K | 0.22% | 83 |
|
|
2019
Q4 | $2.73M | Sell |
73,468
-3,824
| -5% | -$136K | 0.18% | 96 |
|
|
2019
Q3 | $2.63M | Buy |
77,292
+55
| +0.1% | +$2K | 0.19% | 92 |
|
|
2019
Q2 | $3.17M | Sell |
77,237
-427
| -0.5% | -$17K | 0.24% | 83 |
|
|
2019
Q1 | $3.13M | Sell |
77,664
-43
| -0.1% | -$1.72K | 0.25% | 85 |
|
|
2018
Q4 | $3.22M | Sell |
77,707
-4,762
| -6% | -$198K | 0.31% | 70 |
|
|
2018
Q3 | $3.45M | Buy |
82,469
+1,217
| +1% | +$46.9K | 0.28% | 76 |
|
|
2018
Q2 | $2.8M | Sell |
81,252
-604
| -0.7% | -$20.6K | 0.25% | 83 |
|
|
2018
Q1 | $2.76M | Buy |
81,856
+11,132
| +16% | +$383K | 0.27% | 82 |
|
|
2017
Q4 | $2.43M | Buy |
70,724
+9,636
| +16% | +$329K | 0.23% | 81 |
|
|
2017
Q3 | $2.07M | Sell |
61,088
-100
| -0.2% | -$3.21K | 0.22% | 82 |
|
|
2017
Q2 | $1.95M | Sell |
61,188
-183
| -0.3% | -$5.77K | 0.22% | 83 |
|
|
2017
Q1 | $1.99M | Sell |
61,371
-232
| -0.4% | -$7.32K | 0.22% | 83 |
|
|
2016
Q4 | $1.9M | Buy |
61,603
+7,770
| +14% | +$237K | 0.22% | 87 |
|
|
2016
Q3 | $1.73M | Sell |
53,833
-3,235
| -6% | -$108K | 0.23% | 87 |
|
|
2016
Q2 | $1.91M | Buy |
57,068
+3,301
| +6% | +$105K | 0.25% | 87 |
|
|
2016
Q1 | $1.51M | Buy |
53,767
+1,660
| +3% | +$47.4K | 0.19% | 86 |
|
|
2015
Q4 | $1.6M | Sell |
52,107
-1,562
| -3% | -$49.1K | 0.22% | 84 |
|
|
2015
Q3 | $1.6M | Sell |
53,669
-174
| -0.3% | -$5.58K | 0.21% | 85 |
|
|
2015
Q2 | $1.71M | Buy |
53,843
+1,568
| +3% | +$51.1K | 0.24% | 82 |
|
|
2015
Q1 | $1.73M | Sell |
52,275
-2,956
| -5% | -$94K | 0.41% | 70 |
|
|
2014
Q4 | $1.63M | Buy |
55,231
+1,264
| +2% | +$36.2K | 0.42% | 72 |
|
|
2014
Q3 | $1.51M | Buy |
53,967
+1,336
| +3% | +$37.5K | 0.4% | 73 |
|
|
2014
Q2 | $1.48M | Buy |
52,631
+3,852
| +8% | +$110K | 0.39% | 73 |
|
|
2014
Q1 | $1.49M | Sell |
48,779
-85
| -0.2% | -$2.53K | 0.42% | 71 |
|
|
2013
Q4 | $1.42M | Buy |
48,864
+4,331
| +10% | +$126K | 0.42% | 68 |
|
|
2013
Q3 | $1.21M | Buy |
44,533
+5,067
| +13% | +$138K | 0.41% | 67 |
|
|
2013
Q2 | $1.05M | Buy |
+39,466
| New | +$1.09M | 0.38% | 68 |
|
Other funds holding PFE
Grimes & Company's PFE Position: Q2 2026 in Review
Grimes & Company increased its Pfizer (PFE) stake by 1.2% in Q2 2026, buying an estimated $257K and bringing the position to 805,088 shares worth $19.4M. The position accounts for 0.42% of the portfolio, ranked #50.
Grimes & Company first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.3M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Grimes & Company held 805,088 shares of Pfizer worth $19.4M as of Q2 2026.
- Grimes & Company bought 9,806 Pfizer shares in Q2 2026, an estimated $257K.
- Pfizer made up 0.42% of Grimes & Company's portfolio in Q2 2026, its #50 holding.
- Grimes & Company first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Grimes & Company's Pfizer position peaked at $22.3M in Q1 2026.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.